Integrated Nano-Trojan Horse Protocol for Restoring Cellular Communication in Solid Tumors: A Disruptive Conceptual Framework

Background: Solid tumors present formidable therapeutic challenges due to metabolic reprogramming (Warburg effect) and disrupted intercellular communication networks. Conventional cytolytic approaches often fail to address foundational mechanisms of tumor autonomy. Objective: This conceptual paper introduces a novel integrative framework—Nano-Enabled Communication Restoration (NECR)—merging insulin-targeted nanotechnology with near-infrared (NIR)-activated immunomodulation to restore disrupted cellular communication in solid tumors. Methods: We propose a unified mathematical framework with explicit model hierarchy: (1) baseline growth dynamics (Gompertz, logistic, von Bertalanffy); (2) spatial invasion and transport (Fisher-KPP, advection-diffusion); (3) vascular-tumor coupling (Hahnfeldt extension); and (4) treatment-integrated stochastic core. The NECR protocol employs insulin-conjugated nanoparticles (20–100 nm, zeta potential -10 to +10 mV pH-switchable) as Trojan horses to deliver ECM-restorative enzymes and NIR-sensitive modulators. Treatment effects are explicitly incorporated via receptor-limited drug kinetics, pH-triggered release (Henderson-Hasselbalch), photobiomodulation terms, and immune reactivation components. Synthetic data validation follows TCGA-BRCA distributions with hierarchical Bayesian uncertainty quantification and global Sobol sensitivity analysis. Results: In silico Monte Carlo simulations (n=100 runs) under idealized modeling assumptions predict substantial tumor growth suppression, with simulated reductions reaching as high as 96–99.8% in idealized simulations at days 40–100 compared to untreated controls. These theoretical upper bounds reflect synergistic mechanisms but require empirical validation. Global sensitivity analysis identifies drug efficacy and NIR potency as dominant parameters, supporting targeted optimization priorities. Conclusions: NECR offers a theoretically rigorous, mechanistically grounded framework for remission induction through nano-light synergy. While experimental validation remains pending, the enhanced mathematical formalism, comprehensive parameterization, and proposed verification roadmap provide a robust foundation for translational development. All derivations, code, and synthetic datasets are provided for reproducibility. The framework is designed to be modular and adaptable to other solid tumors by substituting subtype-specific parameters. Keywords: Cancer therapy; Nanotechnology; Cellular communication; NIR photobiomodulation; Mathematical modeling; Tumor angiogenesis; Bayesian inference; Synthetic data validation背景：实体瘤因代谢重编程（瓦伯格效应，Warburg effect）及细胞间通讯网络紊乱，面临极具挑战性的治疗困境。传统溶细胞疗法往往难以触及肿瘤自主性的核心机制。 研究目的：本概念性研究提出一种新型整合框架——纳米介导通讯修复（Nano-Enabled Communication Restoration, NECR），将靶向胰岛素的纳米技术与近红外（near-infrared, NIR）激活的免疫调节手段相结合，旨在修复实体瘤中紊乱的细胞间通讯。 研究方法：本研究提出一套具备明确模型层级的统一数学框架：(1) 基线生长动力学（冈珀茨模型Gompertz、逻辑斯蒂模型logistic、冯·贝塔朗菲模型von Bertalanffy）；(2) 空间侵袭与转运（费希尔-科列特-波焦模型Fisher-KPP、对流扩散advection-diffusion）；(3) 血管-肿瘤耦合（哈恩费尔特扩展模型Hahnfeldt extension）；(4) 整合治疗的随机核心模块。NECR治疗方案采用胰岛素偶联纳米颗粒（粒径20–100 nm，zeta电位-10至+10 mV，pH响应型）作为特洛伊木马，递送细胞外基质（extracellular matrix, ECM）修复酶与近红外敏感调节剂。治疗效应通过受体限制性药物动力学、pH触发释放（亨德森-哈塞尔巴尔赫方程Henderson-Hasselbalch）、光生物调节（photobiomodulation）项以及免疫再激活组分进行显性建模。合成数据验证遵循癌症基因组图谱-乳腺浸润性癌（TCGA-BRCA）的分布特征，采用分层贝叶斯不确定性量化与全局索伯尔敏感性分析进行验证。 研究结果：在理想化建模假设下开展的计算机模拟（in silico）蒙特卡洛模拟（Monte Carlo，共100次重复运行）结果显示，实体瘤生长可获得显著抑制；与未处理对照组相比，理想化模拟中第40–100天的肿瘤体积模拟降幅最高可达96–99.8%。此类理论上限值反映了协同作用机制，但仍需实验验证。全局敏感性分析结果表明，药物效力与近红外介导效力为核心主导参数，可为靶向优化提供优先级参考。 结论：NECR框架通过纳米-光协同作用，为肿瘤缓解诱导提供了理论严谨、机制明确的研究路径。尽管实验验证仍待开展，但优化后的数学形式化体系、全面的参数化方案以及提出的验证路线图，为转化研究开发奠定了坚实基础。本研究提供了全部推导过程、代码与合成数据集以保障研究可重复性。该框架设计为模块化结构，可通过替换亚型特异性参数适配其他实体瘤研究。 关键词：癌症治疗；纳米技术；细胞间通讯；近红外光生物调节（NIR photobiomodulation）；数学建模；肿瘤血管生成；贝叶斯推断；合成数据验证